Skip to main content

Idexx Laboratories Inc. Value Stock - Dividend - Research Selection

Idexx

ISIN: US45168D1046 , WKN: 888210

Market price date:
Market price:  


Fundamental data and company key figures of the share

Annual reports in
Key figures
Cash flow
Net operating cash flow
Capital Expenditures
Free cash flow
Balance sheet
Total Equity
Liabilities & Shareholders equity
Income statement
Net income
Eps (diluted)
Diluted shares outstanding
Net sales/revenue

Fundamental ratios calculated on:

Ratios
Key figures
Cash flow
P/C
 
P/FC
Balance sheet
ROI
ROE
Income statement
P/E
Div. Yield %
P/B
P/S


Do you want to do make a detailed fundamental analysis of this stock?

✓ NEW Fundamental API Access to 500 data points per month
Fundamental data up to 25 years
Comparison to all other stocks by the FScore
Time saving!

How our site works ...

Non-binding 7 days without automatic subscription
 No termination required after the free week
Finanzoo fundamental analysis
Data updated daily
Virtual depots
Share alarms via email
Subscription can be canceled at any time at the end of the month 
Choice of desired shares
Over 2000 stock analyzes available
Bitcoin payment possible if you do not want to subscribe

Price for monthly subscription $ 19.99 / month including VAT.



Description Data
Symbol
Market Capitalization USD
Country
Indices
Sectors
Raw Data Source
Stock Split
Internet


Description of the company

IDEXX Laboratories, Inc., together with its subsidiaries, develops, manufactures, and distributes products and services primarily for the companion animal veterinary, livestock and poultry, dairy, and water testing markets worldwide. It operates through Companion Animal Group; Water Quality Products; Livestock, Poultry and Dairy; and Other segments. The company provides point-of-care veterinary diagnostic products, including instruments, consumables, and rapid assay test kits; veterinary reference laboratory diagnostic and consulting services; practice management and diagnostic imaging systems and services for veterinarians; and biological materials testing, and laboratory animal diagnostic instruments and services for biomedical research community. It also offers diagnostic and health-monitoring products for livestock, poultry, and dairy markets; products that test water for various microbiological contaminants; and point-of-care electrolytes and blood gas analyzers that are used in the human point-of-care medical diagnostics market. The company markets its products through marketing, customer service, sales, and technical service groups, as well as through independent distributors and other resellers. IDEXX Laboratories, Inc. was founded in 1983 and is headquartered in Westbrook, Maine.

The Finanzoo GmbH assumes no liability for the accuracy of the information! All information is provided without warranty. Sources:: www.bundesanzeiger.de, www.sec.gov,


NEWS


Idexx Laboratories price target raised to $460 from $420 at Stifel

2025-05-02
Stifel raised the firm’s price target on Idexx Laboratories (IDXX) to $460 from $420 and keeps a Hold rating on the shares. The firm says that the company’s Q1 results were not surprising, but the stock’s reaction was a bit stronger than expected. Stifel will continue to monitor the uptake of Cancer Dx and inVue, but for now the firm believes the near-term contribution is already reflected in estimates. Published first on TheFly – the ultimate source for real-time, market-moving breaking financi

IDEXX Laboratories [NasdaqGS:IDXX] Raises 2025 Guidance and Reports Q1 Growth in Revenue and EPS

2025-05-02
IDEXX Laboratories (NasdaqGS:IDXX) experienced a 13% price increase over the last month, spurred by robust first-quarter earnings results and an optimistic upward revision in corporate guidance. The company reported an increase in sales and net income compared to the previous year, projecting confidence for the remainder of 2025. These positive events coincided with a broader market uptick, including a strong U.S. jobs report and potential trade talk optimism, both bolstering the S&P 500's...

IDEXX Laboratories Inc (IDXX) Q1 2025 Earnings Call Highlights: Strong Organic Growth Amid ...

2025-05-02
IDEXX Laboratories Inc (IDXX) reports robust revenue growth driven by diagnostics and consumables, despite facing headwinds in clinical visits and foreign exchange impacts.

IDEXX Laboratories Inc. stock outperforms competitors on strong trading day

2025-05-01
IDEXX Laboratories Inc. stock outperforms competitors on strong trading day

IDXX Q1 Earnings Beat, FY25 View Raised, Stock Up in Pre-Market

2025-05-01
IDEXX delivers year-over-year earnings and revenue growth in the first quarter of 2025.

Compared to Estimates, Idexx (IDXX) Q1 Earnings: A Look at Key Metrics

2025-05-01
Although the revenue and EPS for Idexx (IDXX) give a sense of how its business performed in the quarter ended March 2025, it might be worth considering how some key metrics compare with Wall Street estimates and the year-ago numbers.

Does IDEXX Laboratories (NASDAQ:IDXX) Deserve A Spot On Your Watchlist?

2025-05-01
For beginners, it can seem like a good idea (and an exciting prospect) to buy a company that tells a good story to...

Idexx Laboratories (IDXX) Beats Q1 Earnings Estimates

2025-05-01
Idexx (IDXX) delivered earnings and revenue surprises of 1.37% and 1.77%, respectively, for the quarter ended March 2025. Do the numbers hold clues to what lies ahead for the stock?

Idexx: Q1 Earnings Snapshot

2025-05-01
WESTBROOK, Maine (AP) — Idexx Laboratories Inc. IDXX) on Thursday reported first-quarter profit of $242.7 million. On a per-share basis, the Westbrook, Maine-based company said it had profit of $2.96.

IDEXX Laboratories, Inc. (IDXX) Q1 2025 Earnings Conference Call Transcript

2025-05-01
IDEXX Laboratories, Inc. (NASDAQ:IDXX) Q1 2025 Earnings Conference Call May 1, 2025 8:30 AM ETCompany ParticipantsAndrew Emerson - EVP, CFO and TreasurerJay...